EVERSANA is proud to sponsor Access USA in Philadelphia, PA from March 18-20. Visit our booth or schedule a meeting with EVERSANA’s team of Patient Services experts.
Hear From Our Experts
- Rare Disease Summit, Innovation Track
- Day 2, Wednesday, 3/19 | 8:15 – 8:45 a.m.
- Optimizing the Exclusive Specialty Pharmacy Model: Weighing the Impact for Manufacturers, Pharmacies and Clinicians
- Presenters:
- Lindsay Reel, Vice President, Pharmacy Practice & Specialty Solutions
- Marshall Kemp, Vice President, Patient Services
Achieve Operational Excellence in Rare Disease Product Launches
Rare and orphan drug manufacturers are becoming increasingly aware that new models and new approaches are needed for a successful product launch. With experience in 25 disease states, EVERSANA COMPLETE Commercialization® is uniquely positioned to remove friction in commercialization to enable an accelerated path to market introduction for critical therapies. Powered by artificial intelligence (AI), machine learning (ML), and data and analytics, our end-to-end model supplies predictive analytics to reach patients, improves access to therapy and facilitates positive outcomes.
Reduce Barriers With Affordability, Copay and Patient Assistance Programs
EVERSANA’s elevated HIPAA- and government-compliant affordability solutions are driven by predictive analytics and patient profile segmentation to offer a patient-first, cost-effective and outcomes-based model designed to directly alleviate patients’ financial burdens and drive therapy adoption. In addition, our solutions offer a direct-to-patient payment method to cover out-of-pocket costs and ensure patients receive the full benefits of the program to keep them on therapy.
Additionally, our custom-built patient assistance programs fuse technology and automation to improve operational efficiencies, ultimately minimizing the confusion and frustrations felt by patients and caregivers.
Improve Accuracy and Efficiency in Benefits Verification With ACTICS® eAccess
By leveraging data and AI capabilities of ACTICS by EVERSANA across the patient journey, EVERSANA can predict patient-switching behaviors that impact adherence and engagement. This information also powers the optimization of our hub and affordability programs and deploys the “next best action” for each patient, leading to an improvement in patient adherence of up to 50% over a traditional hub program.
EVERSANA’s patient services simplify and expedite the patient journey. Our hub accelerates patient onboarding by supplying real-time eligibility determination, self-enrollment with support options and e-prescribing. Additionally, ACTICS® eAccess, EVERSANA’s new proprietary eBV and ePA platform, verifies patient coverage for pharmacy benefit manager and major medical with a greater than 90% success rate in seconds rather than days.
Utilize Digital Intake and Telehealth to Enhance Access With the Direct-to-Patient Care Model
EVERSANA’s Direct-to-Patient Model breaks down barriers by offering patients easy access to healthcare providers via telehealth and personalized care plans. The self-guided platform streamlines consultations and prescriptions, allowing providers to meet patients wherever they are. By eliminating the complexities of in-office visits and pharmacy wait times, patients enjoy a convenient, efficient experience. This model is transforming patient care by redefining how consultations, prescriptions, and payment processes are handled.
Ensure Patients Receive Therapies When and Where They Need Them
Our specialty pharmacy model connects patients, providers and payers to offer direct-to-patient dispensing and administration. In addition, data-driven patient profiling can determine customized outreach to provide education and deliver white-glove support to patients, driving brand loyalty and adherence.
EVERSANA addresses in-office administration challenges and reimbursement risks with buy and bill by providing procurement flexibility, reducing financial burdens and ensuring timely patient access to therapies.